Ivermectin/Pyrantel Pamoate Chewable 68Mcg/163Mg

Verify with FDA CVM →

4,379 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
4,379
Total Reports
36
Deaths Reported
80.0%
Death Rate

Active Ingredients

Ivermectin/Pyrantel Pamoate Chewable 68Mcg/163Mg

Administration Routes

OralUnknownSubcutaneous

Species Affected

Dog 3,953
Unknown 421
Human 2
Other Canids 1
Iguana 1
Cat 1

Most Affected Breeds

Unknown 432
Crossbred Canine/dog 370
Shih Tzu 265
Terrier - Yorkshire 251
Chihuahua 216
Dog (other) 193
Dachshund (unspecified) 165
Maltese 147
Schnauzer - Miniature 127
Dog (unknown) 120

Most Reported Reactions

Digestive tract disorder NOS 1,711
Vomiting 1,053
Lack of efficacy (endoparasite) - hookworm 881
INEFFECTIVE, HEARTWORM LARVAE 538
INEFFECTIVE, ASCARIDS NOS 532
Cardiac disorder NOS 528
Diarrhoea 432
Lethargy (see also Central nervous system depression in 'Neurological') 423
Lack of efficacy - NOS 290
Tablets, Abnormal 222
Lack of efficacy (protozoa) - Coccidia 167
Behavioural disorder NOS 113

Outcome Breakdown

Outcome Unknown
2,242 (56.5%)
Recovered/Normal
1,168 (29.4%)
Recovered with Sequela
319 (8.0%)
Ongoing
205 (5.2%)
Died
26 (0.7%)
Euthanized
11 (0.3%)

Data Summary

Metric Value
Total adverse event reports 4,379
Reports involving death 36
Case-fatality rate (reported events) 80.0%
Distinct species in reports 6
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Ivermectin/Pyrantel Pamoate Chewable 68Mcg/163Mg Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 4,379 adverse event reports referencing Ivermectin/Pyrantel Pamoate Chewable 68Mcg/163Mg, including 36 reports in which the animal died — a 80.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Ivermectin/Pyrantel Pamoate Chewable 68Mcg/163Mg. Reported administration routes include Oral, Unknown, Subcutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Ivermectin/Pyrantel Pamoate Chewable 68Mcg/163Mg reports are Dog (3,953 reports), Unknown (421 reports), Human (2 reports), with Dog accounting for the largest share. Within those species, Unknown (432), Crossbred Canine/dog (370), Shih Tzu (265) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Ivermectin/Pyrantel Pamoate Chewable 68Mcg/163Mg are Digestive tract disorder NOS (1,711), Vomiting (1,053), Lack of efficacy (endoparasite) - hookworm (881), INEFFECTIVE, HEARTWORM LARVAE (538). Of the 3,971 reports with a coded outcome, Outcome Unknown is the leading category at 56.5%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Ivermectin/Pyrantel Pamoate Chewable 68Mcg/163Mg.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial